Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Iris Hall

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Anatomy

Cultured Tumor Cells

Chemicals & Drugs

Disorders

Leukemia L1210

Procedures

Antitumor Drug Screening Assays

Concepts & Ideas

Structure-Activity Relationship

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
43
Spielvogel, BF
35
Sood, A
29
Izydore, RA
16
Miller, MC
12
Barnes, BJ
10
Elkins, AL
10
Lee, Kuo-Hsiung
9
Warren, AE
8
West, DX
8
Ward, Stacy
8
Wyrick, SD
8
Schwab, Ute
8
Ives, Timothy
8
Chaney, Stephen
5
Shaw, Barbara Ramsay

Sign-in to see all Coauthors

Publications

TOP 3
Hall I H; Schwab U; Ward E S; Ives T
In vitro anti-inflammatory effects and immunomodulation by gemifloxacin in stimulated human THP-1 monocytes.
Hall Iris H; Schwab Ute E; Ward E Stacy; Rublein John C; Butts John D; Ives Timothy J
Human THP-1 monocyte uptake and cellular disposition of 14C-grepafloxacin.
Hall Iris H; Schwab Ute E; Ward E Stacy; Ives Timothy
Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Iris Hall (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2004: Hall I H; Schwab U; Ward E S; Ives T
In vitro anti-inflammatory effects and immunomodulation by gemifloxacin in stimulated human THP-1 monocytes.
Die Pharmazie 2004;59(9):713-9.
2004: Hall Iris H; Schwab Ute E; Ward E Stacy; Rublein John C; Butts John D; Ives Timothy J
Human THP-1 monocyte uptake and cellular disposition of 14C-grepafloxacin.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2004;10(1):11-8.
2003: Hall Iris H; Schwab Ute E; Ward E Stacy; Ives Timothy
Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions.
International journal of antimicrobial agents 2003;22(6):579-87.
2003: Hall Iris H; Schwab Ute E; Ward E Stacy; Ives Timothy J
Effects of alatrofloxacin, the parental prodrug of trovafloxacin, on phagocytic, anti-inflammatory and immunomodulation events of human THP-1 monocytes.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2003;57(8):359-65.
2003: Hall Iris H; Schwab Ute E; Ward E Stacy; Ives Timothy J
Effects of moxifloxacin in zymogen A or S. aureus stimulated human THP-1 monocytes on the inflammatory process and the spread of infection.
Life sciences 2003;73(21):2675-85.
2003: Ives Timothy J; Schwab Ute E; Ward E Stacy; Hall Iris H
In-vitro anti-inflammatory and immunomodulatory effects of grepafloxacin in zymogen A- or Staphylococcus aureus-stimulated human THP-1 monocytes.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2003;9(2):134-43.
2003: Evans Michael A; Smith Daniel C; Holub Justin M; Argenti Anthony; Hoff Mafoloe; Dalglish Gerard A; Wilson Donna L; Taylor Brett M; Berkowitz Joshua D; Burnham Bruce S; Krumpe Keith; Gupton John T; Scarlett Tanya C; Durham Jr Richard W; Hall Iris H
Synthesis and cytotoxicity of substituted ethyl 2-phenacyl-3-phenylpyrrole-4-carboxylates.
Archiv der Pharmazie 2003;336(3):181-90.
2003: Hall Iris H; Durham Richard W; Tram Min; Mueller Stephanie; Ramachandran Bhaskar M; Sneddon Larry G
Cytotoxicity and mode of action of vanada- and niobatricarbadecaboranyl monohalide complexes in human HL-60 promyelocytic leukemia cells.
Journal of inorganic biochemistry 2003;93(3-4):125-31.
2002: Hall Iris H; Schwab Ute E; Ward E Stacy; Butts John D; Wolford Eric T; Ives Timothy J
Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes.
International journal of antimicrobial agents 2002;20(5):348-60.
2002: Scarlett Tanya C; Durham Richard W; Hall Iris H; Crosswicks Richard J; Berkowitz Joshua D; Burnham Bruce S
Synthesis and cytotoxicity of cyanoborane adducts of n6-benzoyladenine and 6-triphenylphosphonylpurine.
Metal-based drugs 2002;9(1-2):19-32.
2001: Barnes B J; Izydore R A; Eakin A E; Hall I H
Mechanism of action of the antitumor agents 6-benzoyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: potent inhibitors of human type II inosine 5'-monophosphate dehydrogenase.
International journal of cancer. Journal international du cancer 2001;94(2):275-81.
2001: Hall I H; Barnes B J; Rowell J E; Shaffer K A; Cho S E; West D X; Stark A M
Cytotoxicity of 2-aldo- and 2-ketopyridine-N(4)-substituted thiosemicarbazones and mode of action in human Tmolt4 cells.
Die Pharmazie 2001;56(8):648-53.
2001: Barnes B J; Izydore R A; Eakin A E; Hall I H
Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenase.
The Journal of pharmacology and experimental therapeutics 2001;298(2):790-6.
2001: Barnes B J; Izydore R A; Hall I H
Analysis of the in vitro inhibition of murine and human tumor cell growth by pyrazole derivatives and a substituted azabicyclo [3.1.0] hexane-2,4-dione.
Anticancer research 2001;21(4A):2313-21.
2001: Hall I H; Barnes B J; Ward E S; Wheaton J R; Shaffer K A; Cho S E; Warren A E
Targeting of human Tmolt4 leukemic type II IMP dehydrogenase by cyclic imide related derivatives.
Archiv der Pharmazie 2001;334(7):229-34.
2001: Barnes B J; Eakin A E; Izydore R A; Hall I H
Implications of selective type II IMP dehydrogenase (IMPDH) inhibition by the 6-ethoxycarbonyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones on tumor cell death.
Biochemical pharmacology 2001;62(1):91-100.
2001: Barnes B J; Izydore R A; Hall I H
Cytotoxicity and mode of action of 1-(1-cyclohexenyl) and 1-unsubstituted 3,5-pyrazolidinediones in human Molt4 T cell leukemia.
Anticancer research 2001;21(3B):1857-68.
2001: Hall I H; Barnes B J; Ward E S; Wheaton J R; Izydore R A
Specific inhibition of type II inosine monophosphate dehydrogenase activity of Tmolt4 T cell human leukaemia cells by 3-methoxy and di-benzohydroxamic acids, maleic hydrazide and malonic acids.
The Journal of pharmacy and pharmacology 2001;53(5):749-55.
2001: Hall I H; Barnes B J; Ward E S; Wheaton J R; Warren A E; Izydore R A
Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones.
Archiv der Pharmazie 2001;334(4):109-16.
2001: Hall I H; Covington D W; Wheaton J R; Izydore R A; Zhou X
Cytotoxicity of 2-ethenyl-2,3-dihydrophthalazine-1,4-diones in murine and human tumor cultured cells.
Die Pharmazie 2001;56(2):168-74.
2001: Izydore R A; Zhang Y; Zhou X; Warren A E; Wheaton J R; Hall I H
The cytotoxicity of 1-(1-phenylalkylideneamino)-2,4-azetidinediones and their mode of action in human and murine tumor cells.
Anticancer research 2001;21(1A):157-65.
2001: Ives T J; Schwab U E; Ward E S; Butts J D; Hall I H
Disposition and functions of clarithromycin in human THP-1 monocytes during stimulated and unstimulated conditions.
Research communications in molecular pathology and pharmacology 2001;110(3-4):183-208.
2000: Hall I H; Lackey C B; Kistler T D; Durham R W; Jouad E M; Khan M; Thanh X D; Djebbar-Sid S; Benali-Baitich O; Bouet G M
Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines.
Die Pharmazie 2000;55(12):937-41.
2000: Barnes B J; Eakin A E; Izydore R A; Hall I H
Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
Biochemistry 2000;39(45):13641-50.
2000: Ibrahim G; Bouet G M; Hall I H; Khan M A
Stability constants of potent cytotoxic copper(II) complexes with furan semicarbazones in ethanolic solutions.
Journal of inorganic biochemistry 2000;81(1-2):29-34.
2000: Hall I H; Lackey C B; Kistler T D; Ives J S; Beraldo H; Ackerman L J; West D X
The cytotoxicity of symmetrical and unsymmetrical bis(thiosemicarbazones) and their metal complexes in murine and human tumor cells.
Archiv der Pharmazie 2000;333(7):217-25.
2000: Hall I H; Lackey C B; Kistler T D; Durham R W; Russell J M; Grimes R N
Antitumor activity of mono- and dimetallic transition metal carborane complexes of Ta, Fe, Co, Mo, or W.
Anticancer research 2000;20(4):2345-54.
2000: Yan Y K; Cho S E; Shaffer K A; Rowell J E; Barnes B J; Hall I H
Cytotoxicity of rhenium(I) alkoxo and hydroxo carbonyl complexes in murine and human tumor cells.
Die Pharmazie 2000;55(4):307-13.
2000: Gupton J T; Burham B S; Krumpe K; Du K; Sikorski J A; Warren A E; Barnes C R; Hall I H
Synthesis and cytotoxicity of 2,4-disubstituted and 2,3,4-trisubstituted brominated pyrroles in murine and human cultured tumor cells.
Archiv der Pharmazie 2000;333(1):3-9.
1999: Gupton J T; Burham B S; Byrd B D; Krumpe K E; Stokes C; Shuford J; Winkle S; Webb T; Warren A E; Barnes C R; Henry J; Hall I H
The cytotoxicity and mode of action of 2,3,4-trisubstituted pyrroles and related derivatives in human Tmolt4 leukemia cells.
Die Pharmazie 1999;54(9):691-7.
1999: MacLauchlin C; Hall I H; Izydore R A
Synthesis and cytotoxic action of 1-oxoalkyl and 1,2-dioxoalkyl-1,2,4-triazolidine-3,5-diones in murine and human tissue cultured cells.
Archiv der Pharmazie 1999;332(7):225-32.
1999: Hall I H; Peaty N J; Henry J R; Easmon J; Heinisch G; Pürstinger G
Investigations on the mechanism of action of the novel antitumor agents 2-benzothiazolyl, 2-benzoxazolyl, and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine.
Archiv der Pharmazie 1999;332(4):115-23.
1999: Hall I H; Izydore R A; Warren A E; Barnes C R
Cytotoxicity and mode of action of aliphatic dicarboxylic acids in L1210 lymphocytic leukemia cells.
Anticancer research 1999;19(1A):205-11.
1999: Miller M C; Sood A; Spielvogel B F; Hall I H
The Hypolipidemic and Anti-Inflammatory Activity of Boronated Aromatic Amino Acids in CF(1) Male Mice.
Metal-based drugs 1999;6(6):337-44.
1999: Hall I H; Chen S Y; Barnes B J; West D X
The hypolipidemic activity of heterocyclic thiosemicarbazones, thioureas and their metal complexes in sprague dawley male rats.
Metal-based drugs 1999;6(3):143-7.
1999: Hall I H; Chen S Y
Substituted 4-hydroxyproline di- and tri-peptides as cytotoxic agents.
Amino acids 1999;16(1):79-89.
1998: Miller M C; Stineman C N; Vance J R; West D X; Hall I H
The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazones.
Anticancer research 1998;18(6A):4131-9.
1998: Burnham B S; Gupton J T; Krumpe K; Webb T; Shuford J; Bowers B; Warren A E; Barnes C; Hall I H
Cytotoxicity of substituted alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 lymphoid leukemia cells.
Archiv der Pharmazie 1998;331(11):337-41.
1998: Hall I H; Taylor K; Izydore R A; Daniels D L
Effects of benzohydroxamic acids on L1210 lymphoid leukemia cell nucleic acid metabolism.
Die Pharmazie 1998;53(11):794-9.
1998: Hall I H; Elkins A; Powell W J; Karthikeyan S; Sood A; Spielvogel B F
Substituted carboranes and polyhedral hydroborate salts as anti-neoplastics.
Anticancer research 1998;18(4A):2617-22.
1998: Hall I H; Taylor K; Izydore R A; Coleman D E; Mitchell J A; Cummings R
The cytotoxic action of 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones and 1,3,5-triazine-4,6-(1 H,5 H)-diones in murine and human tumor cells.
Die Pharmazie 1998;53(6):398-405.
1998: Miller M C; Sood A; Spielvogel B F; Hall I H
Effects of alkyl amine carboxyboranes on L1210 DNA fragmentation and nucleic acid metabolism.
Archiv der Pharmazie 1998;331(5):153-62.
1998: Miller M C; Bastow K F; Stineman C N; Vance J R; Song S C; West D X; Hall I H
The cytotoxicity of 2-formyl and 2-acetyl-(6-picolyl)-4N-substituted thiosemicarbazones and their copper(II) complexes.
Archiv der Pharmazie 1998;331(4):121-7.
1998: Hall I H; Warren A E; Lee C C; Wasczcak M D; Sneddon L G
Cytotoxicity of ferratricarbadecaboranyl complexes in murine and human tissue cultured cell lines.
Anticancer research 1998;18(2A):951-62.
1998: Huang Y; Hall I H
Antineoplastic and cytotoxic activity of beta-alkylamino-(para-substituted)propiophenone and beta-alkylamino-(6-methyl)-naphthone derivatives in murine and human tissue culture cells.
Die Pharmazie 1998;53(2):117-23.
1998: Wang F; Warren A E; Barnes C R; Hall I H
Cytotoxicity of poly(phenolic)sulfonates and their sodium salts in l1210 lymphoid leukemia cells.
Metal-based drugs 1998;5(3):147-60.
1998: Hall I H; Murphy M E; Elkins A L
Anti-inflammatory activity of (polyphenolic)-sulfonates and their sodium salts in rodents.
Metal-based drugs 1998;5(2):67-75.
1998: Miller M C; Sood A; Spielvogel B F; Hall I H
The Synthesis and Antitumor Activity of the Sodium Salt and Copper (II) Complex of N-[(Trimethylamineboryl)-Carbonyl]-L-Phenylalanine Methyl Ester.
Metal-based drugs 1998;5(1):1-9.
1998: Miller M C; Woods C M; Murphy M E; Elkins A; Spielvogel B F; Hall I H
Relationship between amine-carboxyboranes and TNF alpha for the regulation of cell growth in different tumor cell lines.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1998;52(4):169-79.
1997: Miller M C; Sood A; Spielvogel B F; Hall I H
Synthesis and antitumor activity of boronated dipeptides containing aromatic amino acids.
Anticancer research 1997;17(5A):3299-306.
1997: Hall I H; Taylor K; Miller M C; Dothan X; Khan M A; Bouet F M
Cytotoxicity of copper complexes of 2-furaldehyde oxime derivatives in murine and human tissue cultured cell lines.
Anticancer research 1997;17(4A):2411-8.
1997: Hall I H; Izydore R A; Zhou X; Daniels D L; Woodard T; Debnath M L; Tse E; Muhammad R A
Synthesis and cytotoxic action of 3,5-isoxazolidinediones and 2-isoxazolin-5-ones in murine and human tumors.
Archiv der Pharmazie 1997;330(3):67-73.
1997: Hall I H; Elkins A L; Karthikeyan S; Spielvogel B F
The cytotoxicity of 1-(phenylmethyl)-4,7,10-tris-[(4'methylphenyl) sulfonyl]-1,4,7,10-tetraazacyclododecane in human Tmolt3 T leukemic cells.
Anticancer research 1997;17(2A):1195-8.
1997: Hall I H; Elkins A L; Sood A; Tomasz J; Spielvogel B F
The cytotoxicity of adenosine 5'-[N,N-di-(gamma-o-carboranyl)propyl] phosphorodiamidate in human Tmolt3 leukemic cells.
Anticancer research 1997;17(1A):151-6.
1997: Miller M C; Sood A; Spielvogel B F; Bastow K; Hall I H
Cytotoxic action of carboxyborane heterocyclic amine adducts.
Metal-based drugs 1997;4(4):229-41.
1997: Hall I H; Miller M C; West D X
Antineoplastic and Cytotoxic Activities of Nickel(II) Complexes of Thiosemicarbazones.
Metal-based drugs 1997;4(2):89-95.
1996: Hall I H; Elkins A; Sood A; Tomasz J; SpielVogel B F
Boron substituted deoxyribonucleosides as cytotoxic agents.
Anticancer research 1996;16(6B):3709-14.
1996: Huang Y; Hall I H
Antineoplastic activities of alpha-methyl-beta-alkylaminopropiophenone derivatives in tissue culture cells.
Anticancer research 1996;16(6B):3589-95.
1996: Huang Y; Hall I H
Antineoplastic activities of 2,3,4-chloro-substituted beta-alkylaminopropiophenone derivatives in CF1 mice and in murine and human tumor cells.
Anti-cancer drugs 1996;7(5):613-20.
1996: Huang Y; Hall I H
Hypolipidemic activity of 3-amino-1-(2,3,4-mononitro-, mono-, or dihalophenyl)propan-1-ones in rodents.
Archiv der Pharmazie 1996;329(7):339-46.
1996: Huang Y; Hall I H
Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenyl-propanones as hypolipidemic agents in rodents.
Archiv der Pharmazie 1996;329(7):329-38.
1996: Huang Y; Hall I H
Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
Die Pharmazie 1996;51(4):199-206.
1996: Huang Y; Hall I H
Antineoplastic activities of alpha-, beta-, and gamma-alkylaminopropiophenone derivatives in mice and in murine and human tissue culture cells.
Anticancer research 1996;16(2):597-604.
1996: Tse E; Butner L; Huang Y; Hall I H
The anti-inflammatory activity of N-substituted indazolones in mice.
Archiv der Pharmazie 1996;329(1):35-40.
1996: Elkins A L; Eley J G; Miller Iii M C; Hall I H; Sood A; Spielvogel B
Transepithelial Transport and Metabolism of Boronated Dipeptides Across Caco-2 and HCT-8 Cell Monolayers.
Metal-based drugs 1996;3(6):277-86.
1996: Burnham B S; Sood A; Tomasz J; Powell W J; Spielvogel B F; Chen S Y; Hall I H
The hypolipidemic activity of boronated nucleosides in male mice and rats.
Metal-based drugs 1996;3(4):173-83.
1996: Miller M C; Sood A; Spielvogel B F; Shrewsbury R P; Hall I H
The pharmacological activities of the metabolites of N-[(trimethylamineboryl)-carbonyl]-L-phenylalanine methyl ester.
Metal-based drugs 1996;3(5):219-26.
1996: Hall I H; Burnham B S; Elkins A; Sood A; Powell W; Tomasz J; Spielvogel B F
Boronated pyrimidines and purines as cytotoxic, hypolipidemic and anti-inflammatory agents.
Metal-based drugs 1996;3(3):155-60.
1996: Hall I H; Tse E Y; Muhammad R A
Cytotoxicity and antineoplastic activities of alkylamines and their borane derivatives.
Metal-based drugs 1996;3(2):101-12.
1996: Murphy M E; Elkins A L; Shrewsbury R P; Sood A; Spielvogel B F; Hall I H
The Effects of Amine-Carboxyborane Related Derivatives on UMR-106 Bone Metabolism.
Metal-based drugs 1996;3(1):31-47.
1996: Butner L; Huang Y; Tse E; Hall I H
Anti-inflammatory activity of 2,3-dihydrophthalazine-1,4-diones in CF1 mice.
International journal of tissue reactions 1996;18(2-3):47-55.
1996: Butner L; Huang Y; Tse E; Hall I H
Anti-inflammatory and analgesic activities of 3-imino-1-oxoisoindolines in CF1 mice.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1996;50(6-7):290-6.
1996: Hall I H; Wyrick S D
Cytoxicity of [(5,6-dichloro-9a-n-propyl-2,3,9,9a-tetrahydro-3-oxo-1H fluoren-7-yl)oxy]acetic acid, an agent known to reduce brain edema.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1996;50(1):19-23.
1995: Burnham B S; Chen S Y; Sood A; Spielvogel B F; Hall I H
Synthesis and cytotoxicity of amine-borane adducts of cyclohexylamines and toluidines.
Die Pharmazie 1995;50(12):779-83.
1995: Miller M C; Shrewsbury R P; Elkins A L; Sood A; Spielvogel B F; Hall I H
The disposition, tissue distribution, and cellular transport of N-[[(trimethylamino)boryl]carbonyl]-L-phenylalanine methyl ester in CF1 mice.
Journal of pharmaceutical sciences 1995;84(8):933-6.
1995: Hall I H; Wyrick S D
The cytotoxicity of [(N-alkyl-1,3-dioxo-1H,3H-isoindolin-5-yl)oxy]-alkanoic acids in murine and human tissue cultured cell lines.
Anticancer research 1995;15(4):1365-9.
1995: Hall I H; Wyrick S D; Waller C L
The cytotoxicity of [(N-alkyl-1H,3H-1-oxoisoindoline-5-yl-oxyl alkanoates and related benzamides in murine and human tissue cultured cell lines.
Anticancer research 1995;15(4):1359-64.
1995: Burnham B S; Chen S Y; Sood A; Spielvogel B F; Miller M C; Hall I H
The cytotoxicity of 3'-aminocyanoborane-2', 3'-dideoxypyrimidines in murine and human tissue cultured cell lines.
Anticancer research 1995;15(3):951-8.
1995: Hall I H; Wong O T; Chapman J M
Cytotoxicity of imides-N-alkyl semicarbazones, thiosemicarbazones, acetylhydrazones and related derivatives.
Anti-cancer drugs 1995;6(1):147-53.
1995: Hall I H; Izydore R A; Vital T S; Chen S Y; Miller M C; Bernal-Ramirez J A; Okwisa W A; Rajendran K G
The cytotoxic activity of 1-acyl- and 1,2-diacyl-4,4-diethyl-3,5-pyrazolidinediones.
Anticancer research 1995;15(1):199-204.
1995: Woodard T; Debnath M L; Simlot R; Izydore R A; Daniels D L; Wong O T; ElSourady H; Hall I H
Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents.
Pharmaceutical research 1995;12(1):24-38.
1995: Hall I H; Simlot R; Izydore R A
Structure activity relationships of 4-substituted 1-acyl and 1,2-diacyl-1,2,4-triazolidine-3,5-diones as anti-inflammatory agents in rodents.
Archiv der Pharmazie 1995;328(1):5-10.
1995: Hall I H; Rajendran K G; Chen S Y; Wong O T; Sood A; Spielvogel B F
Anti-inflammatory activity of amine-carboxyboranes in rodents.
Archiv der Pharmazie 1995;328(1):39-44.
1995: Rajendran K G; Chen S Y; Sood A; Spielvogel B F; Hall I H
The anti-osteoporotic activity of amine-carboxyboranes in rodents.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1995;49(3):131-40.
1995: Hall I H; Wong O T; Scovill J P
The cytotoxicity of N-Pyridinyl and N-quinolinyl substituted derivatives of phthalimide and succinimide.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1995;49(5):251-8.
1994: Hall I H; Chen S Y; Rajendran K G; Sood A; Spielvogel B F; Shih J
Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes.
Environmental health perspectives 1994;102 Suppl 7():21-30.
1994: Rajendran K G; Burnham B S; Chen S Y; Sood A; Spielvogel B F; Shaw B R; Hall I H
Anti-inflammatory and anti-osteoporotic activities of base-boronated nucleosides and phosphate-boronated nucleotides in rodents.
Journal of pharmaceutical sciences 1994;83(10):1391-5.
1994: Hall I H; Wong O T; Chi L K; Chen S Y
Cytotoxicity and mode of action of substituted indan-1, 3-diones in murine and human tissue cultured cells.
Anticancer research 1994;14(5A):2053-8.
1994: Sood A; Spielvogel B F; Powell W J; Bastow K F; Miller M C; Hall I H
Cytotoxicity of ribo-and arabinoside boron nucleosides in tissue culture cells.
Anticancer research 1994;14(4A):1483-8.
1994: Reynolds D J; Wong O T; Simlot R; Chang J J; Hall I H
Acute toxic and teratogenic effects of cyclic imides in rodents.
Archiv der Pharmazie 1994;327(4):237-45.
1994: Hall I H; Wong O T
The cytotoxicity of 3-imino-1-oxoisoindolines in murine and human tissue culture cells.
Anti-cancer drugs 1994;5(2):207-12.
1994: Simlot R; Izydore R A; Wong O T; Hall I H
Hypolipidemic activity of 4-substituted 1,2-diacyl-1,2,4-triazolidine-3,5-diones in rodents.
Journal of pharmaceutical sciences 1994;83(3):367-71.
1994: Hall I H; Chapman J M; Wong O T
The cytotoxic activity of cyclic imido alkyl ethers, thioethers, sulfoxides, sulfones and related derivatives.
Anti-cancer drugs 1994;5(1):75-82.
1993: Hall I H; Wong O T; Chi L K
The cytotoxicity of N-substituted diphenimides and 6,7-dihydro-5H-dibenz[c,e]azepines.
Anti-cancer drugs 1993;4(6):665-70.
1993: Hall I H; Simlot R; Day P; Wong O T; ElSourady H; Izydore R A
The hypolipidemic effects of 1-acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione in rodents.
Pharmaceutical research 1993;10(8):1206-11.
1993: Hall I H; Murthy A R; Burnham B S
Hypolipidemic activity and toxicity of 3-methoxy-N,N'-diaminophthalamide in rodents.
Archiv der Pharmazie 1993;326(8):467-72.
1993: Hall I H; Wong O T; Hall E S; Chen L K
The cytotoxicity of N-substituted indazolones in murine and human tumor cells.
Anti-cancer drugs 1993;4(3):389-93.
1993: Hall I H; Wong O T; Reynolds D J; Simlot R
Comparison between 6,7-dihydro-5H-dibenz(c,e)azepine and lovastatin as hypolipidemic agents in rats.
Journal of pharmaceutical sciences 1993;82(6):565-70.
1993: Hall I H; Rajendran K G; West D X; Liberta A E
The cytotoxicity of heterocyclic thiosemicarbazones and their metal complexes on human and murine tissue culture cells.
Anti-cancer drugs 1993;4(2):231-40.
1993: Simlot R; Izydore R A; Wong O T; Hall I H
Synthesis and hypolipidemic activity of 4-substituted 1-acyl-1,2,4-triazolidine-3,5-diones in rodents.
Journal of pharmaceutical sciences 1993;82(4):408-15.
1993: West D X; Liberta A E; Rajendran K G; Hall I H
The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxides.
Anti-cancer drugs 1993;4(2):241-9.
1993: Izydore R A; Wong O T; Hall I H
Hypolipidemic activity of 6-alkoxycarbonyl-3-aryl-1,3,5- triazabicyclo[3.1.0]hexane-2,4-diones and 2-alkoxycarbonyl-5-aryl-1,3,5-triazine-4,6(1H,5H)-diones in rodents.
Lipids 1993;28(3):223-9.
1993: Izydore R A; Bernal-Ramirez J A; Okwisa W A; Yarborough L V; Wong O T; Hall I H
Hypolipidemic activity of 1-acyl- and 1,2-diacyl-3,5-pyrazolidinediones.
Die Pharmazie 1993;48(2):111-7.
1993: Hall I H; Reynolds D J; Wong O T; Simlot S
The effects of cyclic imides on lipid absorption from the intestine and on bile lipids and bile acids of Sprague Dawley rats.
Pharmacological research : the official journal of the Italian Pharmacological Society 1993;27(2):129-39.
1993: Hall I H; Wong O T; Reynolds D J; Simlot R; Chang J J
Terephthalic acid in Sprague-Dawley rats as a hypolipidemic agent.
Archiv der Pharmazie 1993;326(1):5-13.
1993: Hall I H; Wong O T; Reynolds D J; Chang J J
The hypolipidemic effects of 2-furoic acid in Sprague-Dawley rats.
Archiv der Pharmazie 1993;326(1):15-23.
1993: Hall I H; Wong O T; Reynolds D J; Simlot R; Chang J J
Hypolipidemic effects of 6-amino-2-mercapto-5-methylpyrimidine-4-carboxylic acid in rats and tissue culture cells.
Journal of pharmaceutical sciences 1993;82(1):60-8.
1993: Hall I H; Burnham B S; Rajendran K G; Chen S Y; Sood A; Spielvogel B F; Shaw B R
Hypolipidemic activity of boronated nucleosides and nucleotides in rodents.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1993;47(2-3):79-87.
1992: Sood A; Shaw B R; Spielvogel B F; Hall E S; Chi L K; Hall I H
The synthesis and anti-neoplastic activity of N2-isobutyryl-2'-deoxyguanosine-N7-cyanoborane derivatives.
Die Pharmazie 1992;47(11):833-8.
1992: Hall I H; Wong O T; Simlot R; Reynolds D J
The effects of N(4-methylphenyl)diphenimide on lipid metabolism of Sprague Dawley rats.
Pharmaceutical research 1992;9(10):1324-9.
1992: Hall I H; Wong O T; Simlot R; Miller M C; Izydore R A
Antineoplastic activities and cytotoxicity of 1-acyl and 1,2-diacyl-1,2,4-triazolidine-3,5-diones in murine and human tissue culture cells.
Anticancer research 1992;12(5):1355-61.
1992: Hall I H; Wong O T; Simlot R; Izydore R A
Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro.
Research communications in chemical pathology and pharmacology 1992;77(3):327-46.
1992: Hall I H; Hall E S; Chi L K; Shaw B R; Sood A; Spielvogel B F
Antineoplastic activity of boron-containing thymidine nucleosides in Tmolt3 leukemic cells.
Anticancer research 1992;12(4):1091-7.
1992: Hall I H; Izydore R; Hall E S; Miller M C; Daniels D L; Debnath M L; Woodard T
The antineoplastic and cytotoxicity of benzohydroxamic acids and related derivatives in murine and human tumor cells.
Anti-cancer drugs 1992;3(3):273-80.
1992: Das M K; Maiti P K; Roy S; Mittakanti M; Morse K W; Hall I H
Relationship of hypolipidemic and antineoplastic activities of tricyclohexyl- and triphenylphosphine boranes, carboxyboranes, cyanoboranes, and related derivatives.
Archiv der Pharmazie 1992;325(5):267-72.
1992: Sood A; Sood C K; Spielvogel B F; Hall I H; Wong O T
Synthesis, cytotoxicity, hypolipidemic and anti-inflammatory activities of amine-boranes and esters of boron analogues of choline and thiocholine.
Journal of pharmaceutical sciences 1992;81(5):458-62.
1992: Hall I H; Izydore R A; Simlot R; Wong O T
Potential aldose reductase inhibitors: 1,2,4-triazolidine-3,5-diones and 2-(3,4,5-trimethoxybenzoyl)-4,4-diethyl-3,5-isoxazolidinedione .
Experientia 1992;48(4):383-6.
1992: Hall I H; Wong O T; Sood A; Sood C K; Spielvogel B F; Shrewsbury R P; Morse K W
Hypolipidaemic activity in rodents of boron analogs of phosphonoacetates and cyanoborane adducts of dialkyl aminomethylphosphonates.
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;25(3):259-70.
1992: Wong O T; Williams W L; Oswald B S; Hall I H
The effects of cyclic imides on lipoprotein receptor binding and degradation of rat and human cells and effects on regulatory enzymes of lipid metabolism.
Research communications in chemical pathology and pharmacology 1992;76(1):3-32.
1992: Sood A; Spielvogel B F; Shaw B R; Carlton L D; Burnham B S; Hall E S; Hall I H
The synthesis and antineoplastic activity of 2'-deoxy-nucleoside-cyanoboranes in murine and human culture cells.
Anticancer research 1992;12(2):335-43.
1992: Hall I H; Hall E S; Wong O T
The anti-neoplastic activity of 2,3-dihydrophthalazine-1,4-dione and N-butyl-2,3-dihydrophthalazine-1,4-dione in human and murine tumor cells.
Anti-cancer drugs 1992;3(1):55-62.
1992: Grippo A A; Hall I H; Kiyokawa H; Muraoka O; Shen Y C; Lee K H
The cytotoxicity of helenalin, its mono and difunctional esters, and related sesquiterpene lactones in murine and human tumor cells.
Drug design and discovery 1992;8(3):191-206.
1992: Hall I H; Wong O T; Reynolds D J; Chang J J
The effects on lipid metabolism of 4-phenyl-5,5-dicarbethoxy-2-pyrrolidenone in Sprague Dawley rats.
Acta pharmaceutica Nordica 1992;4(3):179-86.
1991: Sood C K; Sood A; Spielvogel B F; Yousef J A; Burnham B; Hall I H
Synthesis and antineoplastic activity of some cyano-, carboxy-, carbomethoxy-, and carbamoylborane adducts of heterocyclic amines.
Journal of pharmaceutical sciences 1991;80(12):1133-40.
1991: Hall I H; Reynolds D J; Chang J; Spielvogel B F; Griffin T S; Docks E L
Acute toxicity of amine-boranes and related derivatives in mice.
Archiv der Pharmazie 1991;324(9):573-7.
1991: Spielvogel B F; Sood A; Morse K W; Wong O T; Hall I H
The cytotoxicity of amine-cyanoboranes, amine-cyanoalkylboranes and aminomethyl-phosphonate cyanoborane adducts against the growth of murine and human tissue culture cells.
Die Pharmazie 1991;46(8):592-4.
1991: Hall I H; Morse K W; Spielvogel B F; Sood A
DNA interaction with metal complexes and salts of substituted boranes and hydroborates in murine and human tumor cell lines.
Anti-cancer drugs 1991;2(4):389-99.
1991: Grippo A A; Wyrick S D; Lee K H; Shrewsbury R P; Hall I H
Disposition of an antineoplastic sesquiterpene lactone, [3H]-plenolin, in BDF1 mice.
Planta medica 1991;57(4):309-14.
1991: Sood A; Sood C K; Spielvogel B F; Hall I H; Wong O T; Mittakanti M; Morse K
Synthesis and hypolipidemic activity of amine-carboxyboranes, and their amides and esters in rodents.
Archiv der Pharmazie 1991;324(7):423-32.
1991: Hall I H; Wong O T; Wyrick S D; Simlot R; Shrewsbury R P
Disposition of the hypolipidaemic agent, 6-amino-2-mercapto-5-methylpyrimidine-4-carboxylic acid, in Sprague-Dawley rats.
The Journal of pharmacy and pharmacology 1991;43(5):360-3.
1991: Hall I H; Lee K H
The effects of alpha-methylene-gamma-lactone purines and pyrimidines on L1210 lymphoid leukemia nucleic acid metabolism.
Anticancer research 1991;11(1):337-42.
1991: Izydore R A; Hall I H
Hypolipidemic activity of aliphatic dicarboxylic acids in rodents.
Acta pharmaceutica Nordica 1991;3(3):141-6.
1991: Hall I H; Brotherton R J; Docks E L; Griffin T S; Sood A; Spielvogel B F
Hypolipidemic activity of some hydropolyborate salts in rodents.
Biomedica biochimica acta 1991;50(8):1007-17.
1991: Hall I H; Sood A; Spielvogel B F
The hypolipidemic activity of heterocyclic amine boranes in rodents.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1991;45(8):333-41.
1990: Izydore R A; Debnath M L; Woodard T; Wong O T; Hall I H
Hypolipidemic activity of benzohydroxamic acids and dibenzohydroxamic acids in rodents.
Research communications in chemical pathology and pharmacology 1990;70(3):307-21.
1990: Hall I H; Spielvogel B F; Sood A
The antineoplastic activity of trimethylamine carboxyboranes and related esters and amides in murine and human tumor cell lines.
Anti-cancer drugs 1990;1(2):133-41.
1990: Oswald C B; Chaney S G; Hall I H
Inhibition of DNA synthesis in P388 lymphocytic leukemia cells of BDF1 mice by cis-diamminedichloroplatinum(II) and its derivatives.
Journal of pharmaceutical sciences 1990;79(10):875-80.
1990: Hall I H; Patrick M A; Maguire J H
Hypolipidemic activity in rodents of phenobarbital and related derivatives.
Archiv der Pharmazie 1990;323(9):579-86.
1990: Chapman J M; DeLucy P; Wong O T; Hall I H
Structure activity relationships of imido N-alkyl semicarbazones, thiosemicarbazones and acethydrazones as hypolipidemic agents in rodents.
Lipids 1990;25(7):391-7.
1990: Hall I H; Scoville J P; Reynolds D J; Simlot R; Duncan P
Substituted cyclic imides as potential anti-gout agents.
Life sciences 1990;46(26):1923-7.
1990: Hall I H; Wong O T; Futch G; Scovill J P
Hypolipidemic activity of a series of N-pyridinyl and N-quinolinyl substituted derivatives of phthalimide and succinimides in rodents.
Biomedica biochimica acta 1990;49(1):103-13.
1990: Hall I H; Simlot R; Oswald C B; Murthy A R; elSourady H; Chapman J M
The anti-inflammatory activity of 5H-dibenz[c,e]azepine-5,7(6H)dione, 6,7-dihydro-5H-dibenz[c,e]azepine, N-benzoylbenzamide and 1H-benz[d,e]isoquinoline-1,3(2H)dione derivatives in rodents.
Acta pharmaceutica Nordica 1990;2(6):387-400.
1990: Oswald C B; Chaney S G; Hall I H
Inhibition of nucleic acid synthesis in P388 lymphocytic leukemia cells in culture by cis-platinum derivatives.
Biomedica biochimica acta 1990;49(7):579-87.
1989: Hall I H; Grippo A A; Holbrook D J; Roberts G; Lin H C; Kim H L; Lee K H
Role of thiol agents in protecting against the toxicity of helenalin in tumor-bearing mice.
Planta medica 1989;55(6):513-7.
1989: Chapman J M; Sowell J W; Abdalla G; Hall I H; Wong O T
Hypolipidemic activity of cyclic imido alkyl ethers, thioethers, sulfoxides, and sulfones.
Journal of pharmaceutical sciences 1989;78(11):903-9.
1989: Hall I H; Spielvogel B F; Griffin T S; Docks E L; Brotherton R J
The effects of boron hypolipidemic agents on LDL and HDL receptor binding and related enzyme activities of rat hepatocytes, aorta cells and human fibroblasts.
Research communications in chemical pathology and pharmacology 1989;65(3):297-317.
1989: Oswald C B; Hall I H
The inhibition of P338 lymphocytic leukemia DNA polymerase alpha activity by cis-diamminedichloroplatinum(II) and related derivatives.
Anticancer research 1989;9(4):915-22.
1989: Hall I H; Oswald C B; Wyrick S D; Maguire J H; Shrewsbury R P
Disposition of the hypolipidaemic agent, 2,3-dihydrophthalazine-1,4-dione, in Sprague Dawley rats.
The Journal of pharmacy and pharmacology 1989;41(6):394-7.
1989: Oswald C B; Wyrick S D; Chaney S G; Shrewsbury R O; Hall I H
Disposition of cisplatin derivatives -3H-cis-1,2-diaminocyclohexanedichloroplatinum (II) and 3H-cis-1,2-diaminocyclohexanemalonatoplatinum (II) in BDF1 mice.
Research communications in chemical pathology and pharmacology 1989;64(1):41-58.
1989: Wong O T; Hall I H; Chapman J M
The hypolipidemic activity of 1-N-3-methylphthalimido-butan-3-semicarbazone in rodents.
Pharmaceutical research 1989;6(3):230-4.
1988: Lee K H; Lin Y M; Wu T S; Zhang D C; Yamagishi T; Hayashi T; Hall I H; Chang J J; Wu R Y; Yang T H
The cytotoxic principles of Prunella vulgaris, Psychotria serpens, and Hyptis capitata: ursolic acid and related derivatives.
Planta medica 1988;54(4):308-11.
1988: Hall I H; Murthy A R; Day P A; Clavin J
Effects of 2-(2,4-dimethylphenyl)indan-1,3-dione on serum lipoprotein and lipid metabolism of rodents.
Lipids 1988;23(8):755-60.
1988: Hall I H; Wong O T; Wyrick S D
The effects of phthalimide and saccharin derivatives on low-density lipoprotein (LDL) and high-density lipoprotein (HDL) receptor activity and related enzyme activities.
Pharmaceutical research 1988;5(7):413-20.
1988: Williams W L; Hall I H; Grippo A A; Oswald C B; Lee K H; Holbrook D J; Chaney S G
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivo.
Journal of pharmaceutical sciences 1988;77(2):178-84.
1988: Hall I H; Williams W L; Grippo A A; Lee K H; Holbrook D J; Chaney S G
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones.
Anticancer research 1988;8(1):33-42.
1988: Hall I H; Wong O T; Reynolds D J; Oswald C B
Effects of 2,3-dihydrophthalazine-1,4-dione on Sprague Dawley rats lipid metabolism and serum lipoproteins.
Biomedica biochimica acta 1988;47(4-5):423-33.
1987: Hall I H; Reynolds D J; Wong O T; Oswald C B; Murthy A R
Hypolipidemic activity of o-(N-phthalimido)acetophenone in Sprague Dawley rats.
Pharmaceutical research 1987;4(6):472-9.
1987: Hall I H; Wong O T; Murthy A R; Day P A; Calvin J
The hypolipidemic activity of N(4-methyl-phenyl)diphenimide in rodents.
Pharmacological research communications 1987;19(12):839-58.
1987: Hall I H; Grippo A A; Lee K H; Chaney S G; Holbrook D J
Effect of helenalin and bis(helenalinyl)malonate on nucleic acid and protein synthesis in human KB carcinoma cells.
Pharmaceutical research 1987;4(6):509-14.
1987: Page J D; Chaney S G; Hall I H; Lee K H; Holbrook D J
Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones.
Biochimica et biophysica acta 1987;926(2):186-94.
1987: Hall I H; Spielvogel B F; Sood A; Ahmed F; Jafri S
Hypolipidemic activity of trimethylamine-carbomethoxyborane and related derivatives in rodents.
Journal of pharmaceutical sciences 1987;76(5):359-65.
1987: Murthy A R; Wong O T; Reynolds D J; Hall I H
Synthesis and hypolipidemic activity of 3-imino-1-oxoisoindolines in rodents.
Pharmaceutical research 1987;4(1):21-7.
1987: Hall I H; Maguire J H; Wong O T; Day P A; Alpin R S
A comparison of the S(+) and R(-) enantiomers of 5-ethyl-5-phenylhydantoin as hypolipidemic agents in rodents.
Biomedica biochimica acta 1987;46(7):623-34.
1986: Murthy A R; Maguire J H; Alphin R S; Day P A; Hall I H
Hypolipidemic activity of 3- and 4-phenyl-piperidine-2,6-diones and selected N-substituted derivatives.
Lipids 1986;21(10):617-22.
1986: Hall I H; Griffin T S; Docks E L; Brotherton R J; Futch G
Hypolipidemic activity of N,N-dimethyl-n-octadecylamine borane in rodents.
Journal of pharmaceutical sciences 1986;75(7):706-10.
1985: Hall I H; Gilbert C J; McPhail A T; Morse K W; Hassett K; Spielvogel B F
Antineoplastic activity of a series of boron analogues of alpha-amino acids.
Journal of pharmaceutical sciences 1985;74(7):755-8.
1985: Hall I H; Williams W L; Chaney S G; Gilbert C J; Holbrook D J; Muraoka O; Kiyokawa H; Lee K H
Antitumor agents 68: effects of a series of helenalin derivatives on P-388 lymphocytic leukemia nucleic acid and protein synthesis.
Journal of pharmaceutical sciences 1985;74(3):250-4.
1984: Hall I H; Williams W L; Gilbert C J; McPhail A T; Spielvogel B F
Hypolipidemic activity of tetrakis-mu-(trimethylamine-boranecarboxylato)-bis(trimethylamin e- carboxyborane)-dicopper(II) in rodents and its effect on lipid metabolism.
Journal of pharmaceutical sciences 1984;73(7):973-7.
1984: Hall I H; Spielvogel B F; McPhail A T
Antineoplastic activity of tetrakis-mu-(trimethylamine-boranecarboxylato)-bis (trimethylamine-carboxyborane)dicopper (II) in Ehrlich ascites carcinoma.
Journal of pharmaceutical sciences 1984;73(2):222-5.
1981: Lee K H; Ibuka T; Sims D; Muraoka O; Kiyokawa H; Hall I H; Kim H L
Antitumor agents. 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agents.
Journal of medicinal chemistry 1981;24(8):924-7.
1981: Hall I H; Das M K; Harchelroad F; Wisian-Neilson P; McPhail A T; Spielvogel B F
Antihyperlipidemic activity of amine cyanoboranes, amine carboxyboranes, and related compounds.
Journal of pharmaceutical sciences 1981;70(3):339-41.
1980: Hall I H; Starnes C O; McPhail A T; Wisian-Neilson P; Das M K; Harchelroad F; Spielvogel B F
Anti-inflammatory activity of amine cyanoboranes, amine carboxyboranes, and related compounds.
Journal of pharmaceutical sciences 1980;69(9):1025-9.

Sign-in to see more